Azerbaijan vs Bosnia and Herzegovina: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Azerbaijan
0.3%
in 2024
Bosnia and Herzegovina
0.3%
in 2024
Azerbaijan rank
85th
Bosnia and Herzegovina rank
85th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Azerbaijan
- Bosnia and Herzegovina
How they compare
Azerbaijan currently reports 0.3% against 0.3% in Bosnia and Herzegovina, a difference of 0.0%.
Across all 10 years both countries report, Bosnia and Herzegovina has been ahead every year.
Azerbaijan ranks 85th and Bosnia and Herzegovina ranks 85th of 246 countries.
Bosnia and Herzegovina has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Azerbaijan | Bosnia and Herzegovina | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.2% | 0.3% | 0.1% | Bosnia and Herzegovina |
| 2020s | 0.3% | 0.3% | 0.1% | Bosnia and Herzegovina |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Azerbaijan or Bosnia and Herzegovina?
- Azerbaijan, at 0.3% against 0.3% in Bosnia and Herzegovina as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Azerbaijan and Bosnia and Herzegovina?
- 0.0%, with Azerbaijan ahead.
- How many years of comparable data are there for Azerbaijan and Bosnia and Herzegovina?
- 10 years are reported by both, from 2015 to 2024.
- How do Azerbaijan and Bosnia and Herzegovina rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Azerbaijan ranks 85th and Bosnia and Herzegovina ranks 85th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.